Cargando…
Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience(†)
OBJECTIVES: Decellularized homografts have shown auspicious early results when used for pulmonary valve replacement (PVR) in congenital heart disease. The first clinical application in children was performed in 2002, initially using pre-seeding with endogenous progenitor cells. Since 2005, only non-...
Autores principales: | Sarikouch, Samir, Horke, Alexander, Tudorache, Igor, Beerbaum, Philipp, Westhoff-Bleck, Mechthild, Boethig, Dietmar, Repin, Oleg, Maniuc, Liviu, Ciubotaru, Anatol, Haverich, Axel, Cebotari, Serghei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951634/ https://www.ncbi.nlm.nih.gov/pubmed/27013071 http://dx.doi.org/10.1093/ejcts/ezw050 |
Ejemplares similares
-
Decellularized aortic homografts for aortic valve and aorta ascendens replacement(†)
por: Tudorache, Igor, et al.
Publicado: (2016) -
5-Year results from the prospective European multi-centre study on decellularized homografts for pulmonary valve replacement ESPOIR Trial and ESPOIR Registry data
por: Bobylev, Dmitry, et al.
Publicado: (2022) -
Paediatric aortic valve replacement using decellularized allografts
por: Horke, Alexander, et al.
Publicado: (2020) -
A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR Trial and ESPOIR Registry data
por: Boethig, Dietmar, et al.
Publicado: (2019) -
Residual immune response towards decellularized homografts may be highly individual
por: Ebken, Johannes, et al.
Publicado: (2020)